ch3biosystems2024年价格表
CH3 BioSystems是一家生物技术公司，基于一种全新的受专li保护的化学技术，旨在识别和商业化候选药物和诊断药物。
我们制造促进生物医学研究的新型分子工具。我们的目标是更好地了解影响全球数百万人的癌症、自身免疫疾病、神经发育疾病、病毒性疾病和心血管疾病。
我们的长期愿景是促进基于蛋白质甲基化生物学新兴领域的诊断和药物产品的开发。
特别告知：为保证产品质量与良好性能，所以在购买相应产品的同时我司会收取一定量的运输费用！！！本次报价有效时间为2024年1月5日---2024年12月14日。
| 货号 | 品名 | 规格 | 价格 | 品牌 | 货期 | 价格来源 |
| 92C001 | Human Embryonic Kidney (HEK) - Corporate | Vial | 16074.56 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 800001 | Methylarginine-specific antibody | 20mg | 4554.46 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 800002 | Methylarginine-specific antibody | 100mg | 8653.47 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 810001 | Control antibody reagent | 20mg | 3188.12 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 810002 | Control antibody reagent | 100mg | 5009.91 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 150001 | IgY Anti-2B | 100ml | 6376.24 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 150002 | IgY Anti-DEx3 | 100ml | 6376.24 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 150003 | IgY Anti-survivin | 100ml | 6376.24 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 150004 | IgY Anti-survivin 3B | 100ml | 6376.24 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 820001 | Type I Arginine methyltransferase | 200ml | 26415.86 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 820002 | Type III Arginine methyltransferase | 200ml | 42811.92 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 830001 | Methylation substrate | 10mg | 3370.30 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 830002 | Methylation substrate | 25mg | 5592.88 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 890001 | Methyl donor | 500ml | 2732.68 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 91A001 | PC12 pheochromocytoma | Vial | 7196.05 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 91C001 | PC12 pheochromocytoma - Corporate | Vial | 21432.75 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 91A002 | PC12-C41 variant PC12 cell line | Vial | 7196.05 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 91C002 | PC12-C41 variant PC12 cell line - Corporate | Vial | 21432.75 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 91A003 | PC12Mn variant PC12 cell line | Vial | 7196.05 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 91C003 | PC12Mn variant PC12 cell line - Corporate | Vial | 21432.75 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 92A001 | Human Embryonic Kidney (HEK) | Vial | 5920.80 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 92AP01 | Human Embryonic Kidney (HEK) -Premium | Vial | 9108.92 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 93A001 | HepG2 hepatocellular carcinoma | Vial | 5920.80 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 93AP01 | HepG2 hepatocellular carcinoma - Premium | Vial | 9108.92 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 93C001 | HepG2 hepatocellular carcinoma - Corporate | Vial | 16074.56 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94A001 | E0771 breast adenocarcinoma | Vial | 8198.03 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94AP01 | E0771 breast adenocarcinoma - Premium | Vial | 18217.84 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94C001 | E0771 breast adenocarcinoma - Corporate | Vial | 139312.88 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94A002 | LNCaP Human prostate cancer | Vial | 6376.24 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94AP02 | LNCaP Human prostate cancer - Premium | Vial | 9108.92 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94C002 | LNCaP Human prostate cancer - Corporate | Vial | 16074.56 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94A003 | HeLa Human cervical cancer | Vial | 6376.24 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94AP03 | HeLa Human cervical cancer - Premium | Vial | 13663.38 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94C003 | HeLa Human cervical cancer - Corporate | Vial | 18217.84 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94A012 | PC-3 | Vial | 6376.24 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94AP12 | PC-3 - Premium | Vial | 9108.92 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 94C012 | PC-3 - Corporate | Vial | 16074.56 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 99A001 | Rat tail collagen | 1ml | 4536.24 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 99A002 | Cell Sep | ea | 3279.21 | ch3biosystems | 3-6月 | AMJS澳金沙门 |
| 870001 | Inhibitor A | 100ml | 1457.43 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 870002 | Inhibitor A | 500ml | 3279.21 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 880001 | Inhibitor B | 1ml | 1457.43 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 880002 | Inhibitor B | 5ml | 3279.21 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 840001 | Low ionic strength buffer | 100ml | 261.38 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 860001 | High capacity buffer | 100ml | 261.38 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 110000 | pLuc Reporter Vector | ea | 2700.00 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 110001 | LucNeo | ea | 3600.00 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 110002 | Hsp-6270 | ea | 5980.00 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 110003 | Hsp-3569neo | ea | 5980.00 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
| 110004 | Hsp-3338neo | ea | 5980.00 | ch3biosystems | 4-6周 | AMJS澳金沙门 |
（*此为部分产品价格完整价格请下载文件）
关键词：ch3biosystems、甲基精氨酸特异性抗体、甲基蛋白、ch3biosystems 92C001、ch3biosystems 150001
